2Demoly P, Adkinson N F, Brockow K, et al. International Consensus on drug allergy[J]. Allergy, 2014,69 (4) : 420- 437.
3WHO. International drug monitoring: the role of national centres. Report of a WHO meeting[J]. World Health Organ Tech Rep Ser, 1972,498:1-25.
4Davies D M, Ashton C H, Rao J G, et al. Comprehensive clinical drug information service : first year's experience[J]. Br Med J, 1977, 1(6053) :89-90.
5Pichler W J. Delayed drug hypersensitivity reaetions[J]. Ann Intern Med, 2003,139 (8) = 683 - 693.
6Bircher A J, Scherer Hofmeier K. Drug hypersensitivity reactions : Incon sistency in the use of the classification of immediate and nonimmediate reactions[J]. J Allergy Clin Immunol, 2012,129 ( 1 ) : 263- 264.
7Bousquet P J, Gaeta F, Bousquet-Rouanet L, et al. Provocation tests in diagnosing drug hypersensitivity[J]. Curr Pharm Des, 2008, 14 (27) : 2792- 2802.
8Demoly P, Kropl R, Bircher A, et al. Drug hyperser:sitivity: ques- tionnaire. EAACI interest group on drug hypersensitivity[J]. Aller- gy, 1999,54(9) : 999- 1003.
9Benahmed S, Picot M C, Dumas F, et al. Accuracy of a pharmacovig- ilance algorithm in diagnosing drug hypersensitivity reactions[J]. Arch Intern Med,2005,165(13) :1500-1505.
10Sassolas B, Haddad C, Moekenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis [J]. Clin Pharmaeol Ther,2010,88(1) :60-68.
